Free Trial

Novacyt (NCYT) Insider Trading & Ownership

Novacyt logo
GBX 52.60 -3.80 (-6.74%)
As of 12:00 PM Eastern

Novacyt (LON:NCYT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.10%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
£121,409.48
Number Of
Insiders Selling
(Last 3 Years)
0
Get NCYT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Novacyt stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NCYT Insider Buying and Selling by Quarter

Novacyt Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/7/2022James WakefieldInsiderBuy7,000GBX 117£8,190
3/25/2022David AllmondInsiderBuy43,500GBX 231£100,485
3/18/2022Jean-Pierre CrinelliInsiderBuy3,208GBX 241£7,731.28
3/14/2022James McCarthyInsiderBuy2,360GBX 212£5,003.20
(Data available from 1/1/2013 forward)

NCYT Insider Trading Activity - Frequently Asked Questions

The list of insiders at Novacyt includes David Allmond, James McCarthy, James Wakefield, and Jean-Pierre Crinelli. Learn more on insiders at NCYT.

3.10% of Novacyt stock is owned by insiders. Learn more on NCYT's insider holdings.

Novacyt Key Executives

  • Mr. James Martin McCarthy (Age 58)
    Acting CEO & Director
    Compensation: $354.52k
  • Mr. Steve Gibson
    CFO & Director
  • Bryan Close
    Chief Operations Officer
  • Ms. Mandy Cowling
    Corporate & Investor Relations Manager
  • Mr. David Franks
    Chief Human Resources Officer
  • Paul Oladimeji
    Group Head of R&D
  • Mr. Lyn Dafydd Rees (Age 51)
    Executive Director


This page (LON:NCYT) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners